Bystander T cells in cancer immunology and therapy.

Saved in:
Bibliographic Details
Title: Bystander T cells in cancer immunology and therapy.
Authors: Meier SL; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Satpathy AT; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Wells DK; Immunai, New York, NY, USA. danny@immunai.com.
Source: Nature cancer [Nat Cancer] 2022 Feb; Vol. 3 (2), pp. 143-155. Date of Electronic Publication: 2022 Feb 28.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35228747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bystander T cells in cancer immunology and therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meier+SL%22">Meier SL</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Satpathy+AT%22">Satpathy AT</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wells+DK%22">Wells DK</searchLink>; Immunai, New York, NY, USA. danny@immunai.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Feb; Vol. 3 (2), pp. 143-155. <i>Date of Electronic Publication: </i>2022 Feb 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35228747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-022-00335-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 143
    Titles:
      – TitleFull: Bystander T cells in cancer immunology and therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meier SL
      – PersonEntity:
          Name:
            NameFull: Satpathy AT
      – PersonEntity:
          Name:
            NameFull: Wells DK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2022 Feb
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1